SCHEMBL8529327

SCHEMBL8529327

CC(C)(C)c1cc2cc[nH]c2cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 1/20 0.55
▸ AHR P35869 6/20 0.46
▸ NR4A2 P43354 2/20 0.46
▸ CMA1 P23946 1/20 0.46
▸ F7 P08709 1/20 0.46
▸ LTA4H P09960 1/20 0.46
▸ F3 P13726 1/20 0.46
▸ GPR84 Q9NQS5 1/20 0.42
▸ CFTR P13569 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CYP2A6 P11509 3/20 0.37
▸ TYR P14679 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ RAD51 Q06609 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957459 0.93 CSNK2A1 (0.50) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL8957480 0.84 GPR84 (0.48) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL2272066 0.81 CSNK2A1 (0.55) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL13285075 0.79 GPR84 (0.44) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL396029 0.78 GPR84 (0.42) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL26824096 0.78 GPR84 (0.62) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL30741638 0.78 CFTR (0.47) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL29358322 0.78 GPR84 (0.42) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL613747 0.78 CSNK2A1 (0.69) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL8957501 0.76 GPR84 (0.46) CSNK2A1AHRNR4A2CMA1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834494-A SEROTONIN 5HT2B/2C RECEPTOR ANTAGONISTS; CNS NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS; IRRITABLE BOWEL SYNDROME SMITHKLINE BEECHAM P.L.C. (GB) 1998-11-10 — — US disclosed
EP-0707581-B1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-02-26 — — EP disclosed
CN-1129937-A Indoline derivatives as 5HT2C antagonists SMITHKLINE BEECHAM PLC (GB) 1996-08-28 — — CN disclosed
Send feedback